Boston Scientific (BSX) Restructuring Costs (2009 - 2026)

Boston Scientific (BSX) has 18 years of Restructuring Costs data on file, last reported at $3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Restructuring Costs fell 70.0% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $187.0 million (up 713.04% YoY), and the FY2025 full-year result was $194.0 million, up 1112.5% from the prior year.
• Restructuring Costs declined to $3.0 million in Q1 2026, from $109.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $180.0 million in Q4 2023 to a low of -$18.0 million in Q4 2022.
• A 5-year average of $27.8 million and a median of $8.0 million in 2024 frame the typical range for Restructuring Costs.
• Peak annual rise in Restructuring Costs reached 8200.0% in 2025, while the deepest fall reached 200.0% in 2025.
• Tracing BSX's Restructuring Costs over 5 years: stood at -$18.0 million in 2022, then soared by 1100.0% to $180.0 million in 2023, then slumped by 97.78% to $4.0 million in 2024, then jumped by 2625.0% to $109.0 million in 2025, then sank by 97.25% to $3.0 million in 2026.
• Business Quant data shows BSX's Restructuring Costs at $3.0 million in Q1 2026, $109.0 million in Q4 2025, and -$8.0 million in Q3 2025.